Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/22/2003US20030096286 Oligoribonucleotides and ribonucleases for cleaving RNA
05/22/2003US20030096282 Gtpase-activating protein 1
05/22/2003US20030096280 Targeted transfection of cells using a biotinylated dendrimer
05/22/2003US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/22/2003US20030096278 Determination of nucleotide sequences using overlapping oligonucleotides; obtain genomic nucleotide sequences, incubate with overlapping oligonucleotides, amplify sequences, recover products, determine sequence of product
05/22/2003US20030096273 Methods for immobilizing molecules to a solid phase and uses thereof
05/22/2003US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
05/22/2003US20030096268 Apparatus for use in the amplification and sequence determination of polynucleotide
05/22/2003US20030096267 Essential bacterial genes and their use
05/22/2003US20030096260 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
05/22/2003US20030096256 Additive to add discrimination means and matter maintaining discrimination information which containing the additive
05/22/2003US20030096253 Single nucleotide amplification and detection by polymerase
05/22/2003US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
05/22/2003US20030096249 Nucleic acid molecules and polypeptides for a human cation channel polypeptide
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096246 Terminal sequence of chromomsome for use structure tools in genetically engineered plasmid
05/22/2003US20030096245 Invasive cleavage of nucleic acids
05/22/2003US20030096244 Diagnosis of parasitic infections; obtain sample, extract nucleotide sequences, incubate with primer, amplify sequences, separate products, incubate with probes and detect signal, presence of signal indicates presence of parasite
05/22/2003US20030096241 Method of testing squamous epithelial cells
05/22/2003US20030096237 Determination of the ability of patients to respond to a tumor treatment
05/22/2003US20030096232 High throughput assay system
05/22/2003US20030096229 Manipulating genetic material; obtain cells, disrupt, expose to column, label nucleotide sequences, elute labeled sequences
05/22/2003US20030096228 Nucleotide sequences for use as diagnostic tool for detection of bacteria in sample
05/22/2003US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
05/22/2003US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein
05/22/2003US20030096224 Retentate chromatography and protein chip arrays with applications in biology and medicine
05/22/2003US20030096223 Detection of polynucleotide coding cleavable terminal signal sequence; obtain a genetically engineered cell coding preferential surface protein, expressprotein, exposing the cell to reporter agent, detect signal from surface of cells
05/22/2003US20030096221 Methods of identifying g-couple receptors associated with macrophage-thophic hiv, and diagnostic and therapeutic uses thereof
05/22/2003US20030096220 Capillary array-based sample screening
05/22/2003US20030096016 Methods of kidney transplantation utilizing developing nephric tissue
05/22/2003US20030095989 Chimeric cytolytic viruses for cancer treatment
05/22/2003US20030095987 Recombinant parainfluenza virus expression system and vaccines
05/22/2003US20030095986 Production of a parvovirus vaccine in plants as viral coat protein fusions
05/22/2003US20030095984 Vaccine against mumps containing a Jeryl-Lynn virus strain
05/22/2003US20030095983 Treating obesity, insulin resistance, and type II diabetes
05/22/2003US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095967 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists.
05/22/2003US20030095956 Methods of proliferating undifferentiated neural cells
05/22/2003US20030095954 Growth factor gene fused with secretory signal sequence is introduced into fibroblasts ex-vivo using adenovirus vector; infecting cultured non-hematocytes with the vector; administering the cells
05/22/2003US20030095953 Methods of reversing drug resistance in cancer cells
05/22/2003US20030095949 Introducing into cells viral particles or vector that comprise a polynucleotide encoding a serum protein.
05/22/2003US20030095948 Lentiviral vector construct for transferring nucleotide sequences; comprises transcription regulatory sequences of one or more genes preferentially expressed in endothelial cells of mammals.
05/22/2003US20030095947 Compositions and methods for elimination of unwanted cells
05/22/2003US20030095946 Il-18 as an osteoclastgenic inhibitor
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2473141A1 Macroporous gel, its preparation and its use
05/22/2003CA2468171A1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467258A1 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2466890A1 Novel isoamylases and associated methods and products
05/22/2003CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
05/22/2003CA2466843A1 Salmonella vaccine
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466420A1 A novel saitohin gene and uses of same
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2466346A1 Single nucleotide polymorphisms in gh-1
05/22/2003CA2466279A1 Agents that modulate immune cell activation and methods of use thereof
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2465588A1 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
05/22/2003CA2465337A1 Transgenic animal
05/22/2003CA2464942A1 Signal system and elements used therein
05/22/2003CA2464383A1 Sequence variants of the human growth hormone gene and methods for detection
05/22/2003CA2463639A1 Growth hormone variations in humans and their uses
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1313055A1 Method for processing gene expression data, and processing programs
05/21/2003EP1312920A1 Method of screening remedy for heart failure
05/21/2003EP1312685A2 Oligonucleotide array for detecting the methylation state
05/21/2003EP1312684A2 Quantitative multiplex PCR with high dynamic range
05/21/2003EP1312683A2 Micro-electrical detector on-chip
05/21/2003EP1312682A1 Method of amplifying nucleic acid
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312677A1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof
05/21/2003EP1312676A1 Novel protease gene
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312674A1 Allosteric ribozymes and uses thereof
05/21/2003EP1312673A1 Method of protecting personal information
05/21/2003EP1312672A1 Method of accumulating foreign gene product in plant seed at high level
05/21/2003EP1312671A1 Magnetic particles having lower limit critical solution temperature
05/21/2003EP1312615A2 Exocrine gland tight junction-constituting protein jeap family
05/21/2003EP1312613A2 (1--3)-beta-D-glucan binding domain protein, measuring method using the substance and assay kit
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311930A2 Systems and methods for authenticating a user to a web server
05/21/2003EP1311820A1 Increased separation efficiency via controlled aggregation of magnetic nanoparticles
05/21/2003EP1311709A1 Methods and compositions for directed molecular evolution using dna-end modification
05/21/2003EP1311708A1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor
05/21/2003EP1311706A1 A method of detecting microorganisms
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311703A2 Detection and amplification of rna using target-mediated ligation of dna by rna ligase
1 ... 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 ... 4023